Institutions
|
About Us
|
Help
|
Gaeilge
0
1000
Home
Browse
Advanced Search
Search History
Marked List
Statistics
A
A
A
Author(s)
Institution
Publication types
Funder
Year
Limited By:
Subject = family-history;
4 items found
Sort by
Title
Author
Item type
Date
Institution
Peer review status
Language
Order
Ascending
Descending
25
50
100
per page
Bibtex
CSV
EndNote
RefWorks
RIS
XML
Displaying Results 1 - 4 of 4 on page 1 of 1
Marked
Mark
Hemodynamic profile, compensation deficit, and ambulatory blood pressure
(2018)
Ottaviani, Cristina; Shapiro, David; Goldstein, Iris B.; James, Jack E.; Weiss, Robert
Hemodynamic profile, compensation deficit, and ambulatory blood pressure
(2018)
Ottaviani, Cristina; Shapiro, David; Goldstein, Iris B.; James, Jack E.; Weiss, Robert
Abstract:
This study hypothesized that physiologically grounded patterns of hemodynamic profile and compensation deficit would be superior to traditional blood pressure reactivity in the prediction of daily-life blood pressure. Impedance cardiography-derived measures and beat-to-beat blood pressure were monitored continuously in 45 subjects during baseline and four tasks. Ambulatory blood pressure measures were obtained combining data. from one work day and one off day. The mediating effects of gender and family history of hypertension were considered. Only gender was significantly associated with hemodynamic profile. Regression analysis indicated that typical reactivity measures failed to predict everyday life blood pressure. After controlling for gender and baseline blood pressure, hemodynamic patterns during specific tasks proved to be strong predictors, overcoming limitations of previous reactivity models in predicting real-life blood pressure.
http://hdl.handle.net/10379/9756
Marked
Mark
Prediction of breast cancer risk based on profiling with common genetic variants
(2018)
Mavaddat, Nasim; Pharoah, Paul D. P.; Michailidou, Kyriaki; Tyrer, Jonathan; Brook, Mar...
Prediction of breast cancer risk based on profiling with common genetic variants
(2018)
Mavaddat, Nasim; Pharoah, Paul D. P.; Michailidou, Kyriaki; Tyrer, Jonathan; Brook, Mark N.; Bolla, Manjeet K.; Wang, Qin; Dennis, Joe; Dunning, Alison M.; Shah, Mitul; Luben, Robert; Brown, Judith; Bojesen, Stig E.; Nordestgaard, Børge G.; Nielsen, Sune F.; Flyger, Henrik; Czene, Kamila; Darabi, Hatef; Eriksson, Mikael; Peto, Julian
Abstract:
Background: Data for multiple common susceptibility alleles for breast cancer may be combined to identify women at different levels of breast cancer risk. Such stratification could guide preventive and screening strategies. However, empirical evidence for genetic risk stratification is lacking. Methods: We investigated the value of using 77 breast cancer-associated single nucleotide polymorphisms (SNPs) for risk stratification, in a study of 33 673 breast cancer cases and 33 381 control women of European origin. We tested all possible pair-wise multiplicative interactions and constructed a 77-SNP polygenic risk score (PRS) for breast cancer overall and by estrogen receptor (ER) status. Absolute risks of breast cancer by PRS were derived from relative risk estimates and UK incidence and mortality rates. Results: There was no strong evidence for departure from a multiplicative model for any SNP pair. Women in the highest 1% of the PRS had a three-fold increased risk of developing brea...
http://hdl.handle.net/10379/12688
Marked
Mark
The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast and Ovarian Cancer
(2014)
Kerin, Michael J.; McVeigh, Terri; Dorairaj, Jemima J.; Heneghan, Helen M.; Miller, Nicola
The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast and Ovarian Cancer
(2014)
Kerin, Michael J.; McVeigh, Terri; Dorairaj, Jemima J.; Heneghan, Helen M.; Miller, Nicola
Abstract:
Purpose: A germline microRNA binding site-disrupting variant, the KRAS-variant (rs61764370), is associated with an increased risk of developing several cancers. Because this variant is most strongly associated with ovarian cancer risk in patients from hereditary breast and ovarian families (HBOC), and with the risk of premenopausal triple negative breast cancer, we evaluated the association of the KRAS-variant with women with personal histories of both breast and ovarian cancer, referred to as double primary patients.Experimental Design: Germline DNA from double primary patients was tested for the KRAS-variant (n = 232). Confirmation of pathologic diagnoses, age of diagnoses, interval between ovarian cancer diagnosis and sample collection, additional cancer diagnoses, and family history were obtained when available. All patients were tested for deleterious BRCA mutations.Results: The KRAS-variant was significantly enriched in uninformative (BRCA negative) double primary patients, be...
http://hdl.handle.net/10379/4000
Marked
Mark
The kras-variant is associated with risk of developing double primary breast and ovarian cancer
(2018)
Pilarski, Robert; Patel, Divya A.; Weitzel, Jeffrey; McVeigh, Terri; Dorairaj, Jemima J...
The kras-variant is associated with risk of developing double primary breast and ovarian cancer
(2018)
Pilarski, Robert; Patel, Divya A.; Weitzel, Jeffrey; McVeigh, Terri; Dorairaj, Jemima J.; Heneghan, Helen M.; Miller, Nicola; Weidhaas, Joanne B.; Kerin, Michael J.; McKenna, Megan; Wu, Xifeng; Hildebrandt, Michelle; Zelterman, Daniel; Sand, Sharon; Shulman, Lee P.
Abstract:
Purpose: A germline microRNA binding site-disrupting variant, the KRAS-variant (rs61764370), is associated with an increased risk of developing several cancers. Because this variant is most strongly associated with ovarian cancer risk in patients from hereditary breast and ovarian families (HBOC), and with the risk of premenopausal triple negative breast cancer, we evaluated the association of the KRAS-variant with women with personal histories of both breast and ovarian cancer, referred to as double primary patients. Experimental Design: Germline DNA from double primary patients was tested for the KRAS-variant (n = 232). Confirmation of pathologic diagnoses, age of diagnoses, interval between ovarian cancer diagnosis and sample collection, additional cancer diagnoses, and family history were obtained when available. All patients were tested for deleterious BRCA mutations. Results: The KRAS-variant was significantly enriched in uninformative (BRCA negative) double primary patients, ...
http://hdl.handle.net/10379/13480
Displaying Results 1 - 4 of 4 on page 1 of 1
Bibtex
CSV
EndNote
RefWorks
RIS
XML
Peer Review Status
Peer-reviewed (1)
Unknown (3)
Year
2018 (3)
2014 (1)
built by Enovation Solutions